# Effects of Anti-HIV Therapy on Treatment for Hepatitis C in HCV/HIV Infected Adults

> **NCT00100581** · NA · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 2 (actual)

## Conditions studied

- HIV Infections
- Hepatitis C

## Interventions

- **DRUG:** Efavirenz
- **DRUG:** Lamivudine
- **DRUG:** Lopinavir/ritonavir
- **DRUG:** Pegylated interferon alfa-2a
- **DRUG:** Ribavirin
- **DRUG:** Tenofovir disoproxil fumarate

## Key facts

- **NCT ID:** NCT00100581
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 2007-01
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2021-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00100581

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00100581, "Effects of Anti-HIV Therapy on Treatment for Hepatitis C in HCV/HIV Infected Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00100581. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*